iRhythm Technologies, Inc. (IRTC)

USD 85.95

(-6.01%)

Market Cap (In USD)

2.69 Billion

Revenue (In USD)

492.68 Million

Net Income (In USD)

-123.4 Million

Avg. Volume

480.5 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
55.92-124.115
PE
-
EPS
-
Beta Value
1.229
ISIN
US4500561067
CUSIP
450056106
CIK
1388658
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Quentin S. Blackford
Employee Count
-
Website
https://www.irhythmtech.com
Ipo Date
2016-10-20
Details
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.